Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Arash Rezazadeh is active.

Publication


Featured researches published by Arash Rezazadeh.


Circulation Research | 2006

Postinfarct Cytokine Therapy Regenerates Cardiac Tissue and Improves Left Ventricular Function

Buddhadeb Dawn; Yiru Guo; Arash Rezazadeh; Yiming Huang; Adam B. Stein; Greg Hunt; Sumit Tiwari; Jai Varma; Yan Gu; Sumanth D. Prabhu; Jan Kajstura; Piero Anversa; Suzanne T. Ildstad; Roberto Bolli

We systematically investigated the comparative efficacy of three different cytokine regimens, administered after a reperfused myocardial infarction, in regenerating cardiac tissue and improving left ventricular (LV) function. Wild-type (WT) mice underwent a 30-minute coronary occlusion followed by reperfusion and received vehicle, granulocyte colony-stimulating factor (G-CSF)+Flt-3 ligand (FL), G-CSF+stem cell factor (SCF), or G-CSF alone starting 4 hours after reperfusion. In separate experiments, chimeric mice generated by reconstitution of radioablated WT mice with bone marrow from enhanced green fluorescent protein (EGFP) transgenic mice underwent identical protocols. Mice were euthanized 5 weeks later. Echocardiographically, LV function was improved in G-CSF+FL– and G-CSF+SCF–treated but not in G-CSF–treated mice, whereas LV end-diastolic dimensions were smaller in all three groups. Morphometrically, cytokine-treated hearts had smaller LV diameter and volume. Numerous EGFP-positive cardiomyocytes, capillaries, and arterioles were noted in the infarcted region in cytokine-treated chimeric mice treated with G-CSF+FL or G-CSF+SCF, but the numbers were much smaller in G-CSF–treated mice. G-CSF+FL therapy mobilized bone marrow–derived cells exhibiting increased expression of surface antigens (CD62L and CD11a) that facilitate homing. We conclude that postinfarct cytokine therapy with G-CSF+FL or G-CSF+SCF limits adverse LV remodeling and improves LV performance by promoting cardiac regeneration and probably also by exerting other beneficial actions unrelated to regeneration, and that G-CSF alone is less effective.


The American Journal of the Medical Sciences | 2009

The Role of Human Papilloma Virus in Lung Cancer: A Review of the Evidence

Arash Rezazadeh; Damian A. Laber; Shin-je Ghim; Alfred Ben Jenson; Goetz H. Kloecker

Papillomaviruses are small nonenveloped DNA viruses that infect squamous epithelial cells. These viruses have been found in many organisms. Human papillomaviruses (HPVs) give rise to a large spectrum of epithelial lesions, mainly benign hyperplasia (eg, warts and papillomas) with low malignant potential. There is a subgroup of HPV, the “high-risk” HPV, which is associated with precancerous and cancerous lesions. A small fraction of people infected with high-risk HPV will develop cancers that usually arise many years after the initial infection (Psyrri and Dimaio, Nat Clin Pract Oncol. 2008;5:24–31). Nonsmall cell lung cancer is a heterogeneous disease. The most common histologic subtypes include squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Despite different histologies, nonsmall cell lung cancers are often classified together because of similarities in approach and management of the disease. In this article, we reviewed the current literature on lung cancer and HPV. On the basis of this data, we suggested a possible mechanism of carcinogenesis induced by HPV.


Journal of Molecular and Cellular Cardiology | 2008

The role of TNF-α receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning

Michael P. Flaherty; Yiru Guo; Sumit Tiwari; Arash Rezazadeh; Greg Hunt; Santosh K. Sanganalmath; Xian-Liang Tang; Roberto Bolli; Buddhadeb Dawn

The specific role of TNF-alpha receptors I (TNFR-I, p55) and II (TNFR-II, p75) in myocardial ischemic injury remains unclear. Using genetically engineered mice, we examined the relative effects of TNF-alpha signaling via p55 and p75 in acute myocardial ischemia/reperfusion injury under basal conditions and in late preconditioning (PC). Wild-type (WT) (C57BL/6 and B6,129) mice and mice lacking TNF-alpha (TNF-alpha(-/-)), p55 (p55(-/-)), p75 (p75(-/-)), or both receptors (p55(-/-)/p75(-/-)) underwent 30 min of coronary occlusion and 24 h of reperfusion with or without six cycles of 4-min coronary occlusion/4-min reperfusion (O/R) 24 h earlier (ischemic PC). Six cycles of O/R reduced infarct size 24 h later in WT mice, indicating a late PC effect. This late PC-induced infarct-sparing effect was abolished not only in TNF-alpha(-/-) and p55(-/-)/p75(-/-) mice, but also in p55(-/-) and p75(-/-) mice, indicating that TNF-alpha signaling via both p55 and p75 is necessary for the development of protection. In nonpreconditioned TNF-alpha(-/-), p55(-/-)/p75(-/-), and p75(-/-) mice, infarct size was similar to strain-matched WT mice. In contrast, infarct size in nonpreconditioned p55(-/-) mice was reduced compared with nonpreconditioned WT mice. We conclude that (i) unopposed p75 signaling (in the absence of p55) reduces infarct size following acute ischemia/reperfusion injury in naive myocardium, whereas unopposed p55 signaling (in the absence of p75) has no effect; and (ii) the development of the infarct-sparing effects of the late phase of PC requires nonredundant signaling via both p55 and p75 receptors. These findings reveal a fundamental, heretofore unrecognized, difference between the two TNF-alpha receptors in the setting of myocardial ischemia/reperfusion injury: that is, both p55 and p75 are necessary for the development of protection during late PC, but only signaling via p75 is protective in nonpreconditioned myocardium.


Journal of Molecular and Cellular Cardiology | 2009

The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up

Santosh K. Sanganalmath; Adam B. Stein; Yiru Guo; Sumit Tiwari; Greg Hunt; Robert J. Vincent; Yiming Huang; Arash Rezazadeh; Suzanne T. Ildstad; Buddhadeb Dawn; Roberto Bolli

We have previously reported that administration of granulocyte colony-stimulating factor (G-CSF)+Flt-3 ligand (FL) or G-CSF+stem cell factor (SCF) improves left ventricular (LV) function and halts LV remodeling at 35 d after myocardial infarction (MI). In the current study, we investigated whether these beneficial effects are sustained in the long term - an issue of fundamental importance for clinical translation. Mice undergoing a 30-min coronary occlusion followed by reperfusion received vehicle (group I), G-CSF+FL (group II), G-CSF+SCF (group III), or G-CSF alone (group IV) starting 4 h after reperfusion and were euthanized 48 wk later. LV structure and function were assessed by serial echocardiography before and at 48 h and 4, 8, 16, 32, and 48 wk after MI. During follow-up, mice in group I exhibited worsening of LV function and progressive LV remodeling. Compared with group I, both groups II and III exhibited improved LV EF at 4 wk after MI; however, only in group II was this improvement sustained at 48 wk. Group II was also the only group in which the decrease in infarct wall thickening fraction, the LV dilatation, and the increase in LV mass were attenuated vs. group I. We conclude that the beneficial effect of G-CSF+FL on postinfarction LV dysfunction and remodeling is sustained for at least 11 months, and thus is likely to be permanent. In contrast, the effect of G-CSF+SCF was not sustained beyond the first few weeks, and G-CSF alone is ineffective. To our knowledge, this is the first long-term study of cytokines in postinfarction LV remodeling. The results reveal heretofore unknown differential actions of cytokines and have important translational implications.


The American Journal of the Medical Sciences | 2008

Brain Stem and Clivus Plasmacytoma

Goetz H. Kloecker; Chithra R. Kannan; Damian A. Laber; Arash Rezazadeh

A 62-year-old man presented with progressive cervical pain and double vision. An MRI of the brain revealed a 5-cm enhancing mass in the clivus and brain stem (Figures 1A and B, arrows) extending into the left internal auditory and carotid canal, nasopharynx, sphenoid and cavernous sinuses, without midline shift, or hydrocephalus. Transsphenoidal stereotactic biopsy of the mass showed an atypical plasma cell proliferation with multinucleation and mitotic activity, positive for kappa light chain. He received pulsed high-dose dexamethasone and radiotherapy to the mass with initial symptomatic improvement, but died of progressive disease 4 months later. Plasmacytoma involving brain is extremely rare. Only case reports and small case series have been published and incidence is unknown. Prognosis utilizing multiple myeloma standard treatment is generally poor.


Cardiology in Review | 2003

Recurrent aortic dissection in Marfan's syndrome: possible effects of anticoagulation.

Kantelhardt; Pasnoori; Jai Varma; Arash Rezazadeh; Buddhadeb Dawn

&NA; Recent reports support the role of a valve‐sparing procedure in ascending aortic dissection in patients with Marfan’s syndrome. A 49‐year old woman with Marfan’s syndrome and prior aortic aneurysm repaired with a composite graft presented with sudden‐onset chest pain. Following an initial negative computed tomographic (CT) scan, a long dissection involving the descending thoracic and abdominal aorta was discovered on a repeat CT scan a few hours later. Symptoms improved gradually with optimal medical management and the patient was discharged home on anticoagulant therapy. Although no direct cause‐and‐effect relationship can be established, chronic anticoagulant therapy may accelerate the progression of recurrent dissection in these patients. A valve‐sparing procedure should be considered in eligible patients with Marfan’s syndrome who need operative correction to avoid possible future untoward effects of long‐term anticoagulant therapy.


Proceedings of the National Academy of Sciences of the United States of America | 2005

Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function

Buddhadeb Dawn; Adam B. Stein; Konrad Urbanek; Marcello Rota; Brian Whang; Raffaella Rastaldo; Daniele Torella; Xian Liang Tang; Arash Rezazadeh; Jan Kajstura; Annarosa Leri; Greg Hunt; Jai Varma; Sumanth D. Prabhu; Piero Anversa; Roberto Bolli


Cardiovascular Research | 2004

IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2

Buddhadeb Dawn; Yu-Ting Xuan; Yiru Guo; Arash Rezazadeh; Adam B. Stein; Greg Hunt; Wen Jian Wu; Wei Tan; Roberto Bolli


Journal of Molecular and Cellular Cardiology | 2004

Tumor necrosis factor-α does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning

Buddhadeb Dawn; Yiru Guo; Arash Rezazadeh; Ou Li Wang; Adam B. Stein; Greg Hunt; Jai Varma; Yu-Ting Xuan; Wen Jian Wu; Wei Tan; Xiaoping Zhu; Roberto Bolli


American Journal of Physiology-heart and Circulatory Physiology | 2002

Role of Src protein tyrosine kinases in late preconditioning against myocardial infarction

Buddhadeb Dawn; Hitoshi Takano; Xian Liang Tang; Eitaro Kodani; Supratim Banerjee; Arash Rezazadeh; Yumin Qiu; Roberto Bolli

Collaboration


Dive into the Arash Rezazadeh's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Roberto Bolli

University of Louisville

View shared research outputs
Top Co-Authors

Avatar

Greg Hunt

University of Louisville

View shared research outputs
Top Co-Authors

Avatar

Yiru Guo

University of Louisville

View shared research outputs
Top Co-Authors

Avatar

Adam B. Stein

University of Louisville

View shared research outputs
Top Co-Authors

Avatar

Sumit Tiwari

University of Louisville

View shared research outputs
Top Co-Authors

Avatar

Jai Varma

University of Louisville

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge